#Path2Cures Proceeds to Pennsylvania TOMORROW

August 28, 2014

The Energy and Commerce Committee’s 21st Century Cures initiative will take center stage Friday, August 29, in Lancaster, Pennsylvania, as Health Subcommittee Chairman Joe Pitts (R-PA) will host a roundtable. Pitts has assembled an all-star lineup of health care professionals and innovators to contribute to the cures effort including Dr. Francis Collins, Director of the National Institutes of Health, and Dr. Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration. Energy and Commerce Chairman Fred Upton (R-MI), Health Subcommittee Vice Chairman Michael C. Burgess, M.D. (R-TX), and Health Subcommittee Ranking Member Frank Pallone (D-NJ) will also participate.

“On Friday, the top health leaders in Pennsylvania and the nation’s capital will come together in Lancaster for an important dialogue on how we can accelerate the pace of cures,” said Pitts. “This is a top priority for the Energy and Commerce Committee, and the Health Subcommittee is the tip of the spear in this effort. Our work and conversations continue to boost treatments and cures, spur research and development, and keep the globe’s top innovators and job creators here in the United States. There is no more important initiative that touches more lives than 21st Century Cures.”

Friday’s event will begin at 1:30 p.m. at the Lancaster Farm and Home Center. More details are available online here. C-SPAN is scheduled to record the event and broadcast at a later date to be determined.

Participants and attendees will include:

Dr. Francis S. Collins
Director
National Institutes of Health

Dr. Margaret A. Hamburg
Commissioner
U.S. Food and Drug Administration

Dr. Louis A. Marotti, Jr.
Chief of Neurosurgery
Lancaster Regional Medical Center
Brain Orthopedic Spine Specialists, P.C.

The Honorable James C. Greenwood
President and CEO
Biotechnology Industry Organization

Dr. Norman W. Barton
Vice President
Global Clinical Development Team Leader
Shire

Dr. Lon Cardon
Senior Vice President
Alternative Discovery and Development
GlaxoSmithKline

Dr. William A. Hanlon
Vice President, Head of Global Regulatory Affairs
Covance, Inc.

Mr. Clint Matthews
President and CEO
Reading Health System

Dr. Chi Van Dang
Director, Abramson Cancer Center
University of Pennsylvania

Mr. Caroll H. Neubauer
Chairman and CEO
B. Braun Medical, Inc.

Dr. Joseph W. St. Geme, III
Physician-in-Chief
The Children’s Hospital of Philadelphia

Jennifer Westdyke
Parent of Hydrocephalus Child
Pediatric Hydrocephalus Foundation, Inc.

Read more on the 21st Century Cures initiative here, and join the conversation on Facebook and Twitter using #Path2Cures.

###